CIK: 0001616824
Total reported value
$155.8M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACRS | Aclaris Therapeutics INC | Stock-Other | 21.95% | -2.77% | — | |
| 2 | SGOV | Ishares 0-3 Month Treasury B | ETF-Gov Bonds | 16.20% | — | -3.70% | |
| 3 | AVIR | Atea Pharmaceuticals INC | Stock-Other | 15.83% | +1.27% | +14.41% | |
| 4 | AVU0 | Adverum Biotechnologies INC | Stock-Other | 6.58% | — | — | |
| 5 | ANTX | An2 Therapeutics INC | Stock-Other | 4.93% | — | — | |
| 6 | TIL | Instil Bio INC | Stock-Other | 4.74% | -2.72% | +19.40% | |
| 7 | EPIEUR | Essa Pharma INC | Stock-Other | 4.69% | — | — | |
| 8 | WHWK | Whitehawk Therapeutics INC | Stock-Other | 4.12% | — | +5.00% | |
| 9 | ORMP | Oramed Pharmaceuticals INC | Stock-Other | 3.97% | -0.89% | +20.94% | |
| 10 | ✓ | Ikena Oncology INC | Stock-Other | 3.65% | — | +395.77% | |
| 11 | PMVP | Pmv Pharmaceuticals INC | Stock-Other | 3.25% | -1.48% | +105.28% | |
| 12 | 698 | Achilles Therapeutics Pl-adr | Stock-Other | 2.90% | — | — | |
| 13 | CNTB | Connect Biopharma Holdings Limited | Stock-Other | 1.79% | — | — | |
| 14 | MIST | Milestone Pharmaceuticals In | Stock-Other | 1.67% | — | — | |
| 15 | ✓ | Athira Pharma INC | Stock-Other | 1.01% | — | — | |
| 16 | ASTC | Astrotech CORP | Stock-Other | 0.92% | — | — | |
| 17 | LSTA | Lisata Therapeutics INC | Stock-Other | 0.53% | -0.12% | EXIT | |
| 18 | PVLA | Palvella Therapeutics INC | Stock-Other | 0.31% | — | — | |
| 19 | VTGN | Vistagen Therapeutics INC | Stock-Other | 0.27% | — | — | |
| 20 | 2KZ0 | Kezar Life Sciences INC | Stock-Other | 0.20% | -0.49% | — | |
| 21 | LENZ | Lenz Therapeutics INC | Stock-Other | 0.17% | — | -84.55% | |
| 22 | NXTCEUR | Nextcure INC | Stock-Other | 0.13% | — | -1.06% | |
| 23 | ✓ | Verrica Pharmaceuticals INC | Stock-Other | 0.08% | — | -2.97% | |
| 24 | ✓ | Stock-Other | 0.05% | — | -69.45% | ||
| 25 | ✓ | Hillevax INC | Stock-Other | 0.03% | — | +5.06% |